White paper published on the responsible use of Generative AI in adult social care 

Following the AI in Social Care Summit that was held in March 2025, a white paper summarising the Summit’s findings has been published entitled, ‘The responsible use of Generative AI in adult social care: A value led approach.’ 

The white paper, co-authored by the Oxford Institute for Ethics in AI, the Digital Care Hub and Casson Consulting, looks at what Generative AI is and how it is/can be used in social care, as well as outlining future steps. 

You can read the white paper here: https://www.oxford-aiethics.ox.ac.uk/sites/default/files/2025-04/AI-in-Social-Care-White-Paper-April-2025-Institute-for-Ethics-in-AI.pdf 

Find out more about the March 2025 Summit here: https://www.oxford-aiethics.ox.ac.uk/news/ai-social-care-summit-charting-course-responsible-use-ai-social-care 

More information/resources on the responsible use of Generative AI in social care is available from the Digital Care Hub: https://www.digitalcarehub.co.uk/ai-and-robotics/oxford-project-the-responsible-use-of-generative-ai-in-social-care/

Similar Posts

  • NAPA conference: focus on creativity

    At a lively conference in London in June, held to celebrate NAPA’s 25th year and national programme Arts in Care Homes, a wide variety of speakers shared ideas and experience of encouraging creativity and meaningful engagement in activity. Keynote speaker Jackie Pool, QCS Dementia Care Champion, focused attention on the words ‘meaningful’ and ‘engagement’, suggesting…

  • Rugby players vulnerable to dementia

    Former professional rugby players are 2.5 times more likely than average to experience neurodegenerative conditions like dementia, new research suggests. A study of 412 former rugby players, by Glasgow University, found that they were 2.67 times more likely to develop dementia, over 3 times more likely to develop Parkinson’s, and 15 times more likely to…

  • End of life care

    The government-based Office for Health Improvement and Disparities has produced a palliative and end of life care factsheet covering dementia as well as other conditions.  The factsheet describes patterns of care near the end of life for four of the six conditions that will be included in the government’s forthcoming Major Conditions Strategy – dementia,…

  • Donanemab approval delayed by US drugs regulator 

    The American Food and Drug Administration (FDA) has announced an advisory panel will be convened to scrutinise data on the safety and efficacy of new Alzheimer’s drug donanemab. Donanemab had been expected to be approved by the FDA imminently, but their decision is now delayed until later this year.  UK regulators (along with their European…

  • Casey Commission Terms of Reference published 

    Following the announcement in January that there will be an independent commission into adult social care chaired by Baroness Louise Casey (we reported on this here: https://journalofdementiacare.co.uk/uk-government-announce-casey-commission-into-adult-social-care), the UK Government has now published the Terms of Reference for the Commission.  You can read the Terms of Reference here: https://www.gov.uk/government/publications/independent-commission-into-adult-social-care-terms-of-reference/independent-commission-into-adult-social-care-terms-of-reference  Commenting on the Terms of Reference,…

  • DEEP 10th anniversary

    DEEP – the UK network of dementia voices – will be “shouting out loud and proud” this year to celebrate its 10th anniversary. There will be an online festival on 5 – 9 December with a wide range of sessions, including a mixture of fun and serious discussions, practical activities and the showcasing of DEEP…